CHD
58
10
FOXA
53
8
ESS
47
-4
F
35
-4
XYL
33
-4
NRG
59
-10
BAC
42
-2
BBY
40
2
XRAY
22
2
PYPL
39
-4
BXP
44
-2
BMY
43
-3
NAVI
27
-3
SYY
52
11
VRTX
43
-4
NOV
49
-3
DIS
50
-2
MAS
56
-2
CMG
63
9
FMC
50
-3
CHD
58
10
FOXA
53
8
ESS
47
-4
F
35
-4
XYL
33
-4
NRG
59
-10
BAC
42
-2
BBY
40
2
XRAY
22
2
PYPL
39
-4
BXP
44
-2
BMY
43
-3
NAVI
27
-3
SYY
52
11
VRTX
43
-4
NOV
49
-3
DIS
50
-2
MAS
56
-2
CMG
63
9
FMC
50
-3
Financhill
Back

Larimar Therapeutics Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
56

LRMR
Larimar Therapeutics

Last Price:
7.54
Seasonality Move:
27.07%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Larimar Therapeutics Stock Forecast

  • Over the next 52 weeks, Larimar Therapeutics has on average historically risen by 16% based on the past 10 years of stock performance.
  • Larimar Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Larimar Therapeutics Stock Undervalued?
    The current Larimar Therapeutics [LRMR] share price is $7.74. The Score for LRMR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • LRMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Larimar Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Larimar Therapeutics has on average historically risen by 16% based on the past 10 years of stock performance.

Larimar Therapeutics Stock Rating

Buy
56
Larimar Therapeutics (LRMR) is a Buy

Is Larimar Therapeutics overpriced?

  • Larimar Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Larimar Therapeutics Stock Price History

Is LRMR stock going to rise?

  • The current trend is moderately bearish and LRMR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
larimartx.com

52-Week Data

52-Week High:
13.68
52-Week Low:
2.18

Prediction Charts

Market Cap:
493.86M
Price in USD:
7.74
Volume:
431.25K
Beta:
0.56

Technical Analysis

SMA50:
7.33
SMA100:
7.89
SMA200:
7.95
52-Wk Change:
169.69%

Stock Predictions

  • Is Larimar Therapeutics stock public?
    Yes, Larimar Therapeutics is a publicly traded company.
  • What is the Larimar Therapeutics stock quote today?
    The Larimar Therapeutics stock price is 7.74 USD today.
  • How to buy Larimar Therapeutics stock online?
    You can buy Larimar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-14 6.99 7.25 7.39 6.97
Oct-15 7.23 7.43 7.47 7.02
Oct-16 7.95 7.71 8.34 7.48
Oct-18 7.86 7.76 7.98 7.75
Oct-21 7.72 7.53 7.95 7.39
Oct-22 7.44 7.53 7.55 7.17
Oct-23 7.45 7.35 7.50 7.26
Oct-24 7.36 7.96 8.10 7.29
Oct-25 8.00 8.01 8.34 7.85
Oct-28 8.17 8.02 8.50 7.86
Oct-29 7.96 7.78 8.05 7.74
Oct-30 8.19 8.44 8.68 7.90
Oct-31 8.47 8.23 8.77 8.22
Nov-1 8.23 7.74 8.36 7.63

Larimar Therapeutics Earnings

Larimar Therapeutics Earnings Report: Per Share Larimar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Larimar Therapeutics Forecast Revenue Growth

Larimar Therapeutics Stock Analysis: Historical quarterly revenues per share for Larimar Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.43 per share.

* Larimar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.